LDK378 in Adult Patients With ALK-activated NSCLC Previously Treated With Chemotherapy and Crizotinib
Clinical trial NCT01685060 · COMPLETED
Trial details
- NCT number
- NCT01685060
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-26
- Primary completion
- 2016-03-29
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.